Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chmp
Pharma
PTC gets another chance to keep Translarna's EU authorization
Two negative recommendations from the CHMP were not enough to convince the European Commission that Translarna should be removed from the market.
Eric Sagonowsky
May 20, 2024 8:58am
Amylyx's ALS drug Albrioza rebuffed by EU regulator—again
Oct 13, 2023 11:24am
Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe
Jul 21, 2023 12:20pm
EU regulators recommend pulling Novartis sickle cell med Adakveo
May 26, 2023 11:18am
Amicus' Pompe approval portends a showdown with Sanofi
Mar 28, 2023 10:25am
Biogen vows to contest EMA snub of Aduhelm
Dec 17, 2021 10:50am
